Osamu Asano

E5531, a Pure Endotoxin Antagonist of High Potency

William J. Christ, Osamu Asano, Andrea L. C. Robidoux et al. · Science · 1995 · 321 citations

Pharmacotherapy, Viable Escherichia Coli, Drug Resistance +16

2-Alkynyl-8-aryl-9-methyladenines as Novel Adenosine Receptor Antagonists:  Their Synthesis and Structure−Activity Relationships toward Hepatic Glucose Production Induced via Agonism of the A_2BReceptor

Hitoshi Harada, Osamu Asano, Yorihisa Hoshino et al. · Journal of Medicinal Chemistry · 2000 · 111 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +13

Improved Glucose Tolerance via Enhanced Glucose-Dependent Insulin Secretion in Dipeptidyl Peptidase IV-Deficient Fischer Rats

Tadashi Nagakura, Nobuyuki Yasuda, Kazuto Yamazaki et al. · Biochemical and Biophysical Research Communications · 2001 · 96 citations

Metabolic Syndrome, Glucose Tolerance, Biochemistry +12

Total Synthesis of the Proposed Structure of Rhodobacter sphaeroides Lipid A Resulting in the Synthesis of New Potent Lipopolysaccharide Antagonists

William J. Christ, Pamela D. McGuinness, Osamu Asano et al. · Journal of the American Chemical Society · 1994 · 87 citations

Lipid Analysis, Bioorganic Chemistry, Altmetric Attention Score +18

Antitumor effects of eribulin depend on modulation of the tumor microenvironment by vascular remodeling in mouse models

Ken Ito, Shusei Hamamichi, Takanori Abe et al. · Cancer Science · 2017 · 68 citations · Full text